Drawing for ALL ABOUT BLEEDING

USPTO serial 97722573

ALL ABOUT BLEEDING

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
HAN, JOANNA Y
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ALL ABOUT BLEEDING?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Scott D. Woldow

Scott D. Woldow SMITH, GAMBRELL & RUSSELL, LLP1055 THOMAS JEFFERSON STREET, NWSUITE 400WASHINGTON, DC 20007

Goods and services

ClassDescriptionStatusFirst use
016Printed materials, namely, journals, newsletters, articles and case studies featuring blood related diseases, biopharmaceuticals and biotherapies; Printed publications, namely, brochures, booklets, newsletters, articles, case studies, and teaching materials in the field of blood related diseases; printed educational materials in the field of blood related diseasesACTIVE—
035Promoting public awareness of Von Willebrand disease and blood related diseases, its treatment and its impact on patients, patient families, caregivers and/or healthcare professionals; promoting public awareness of Von Willebrand disease and blood related diseases, its treatment and its impact on patients, patient families, caregivers and/or healthcare professionals by means of public advocacy and patient and caregiver public advocacy; Promoting the donation of blood, volunteer services, and financial resources in the field of blood donations by means of arranging and conducting incentive reward programsACTIVE—
041Healthcare education services, namely, providing educational and awareness educational training programs for patients, caregivers and/or healthcare professionals concerning Von Willebrand disease and blood related diseases, its treatment and its impact on patients, patient families, caregivers and/or healthcare professionals; organizing, planning and conducting educational conventions and educational seminars in the field of Von Willebrand disease and blood related diseases, its treatment and its impact on patients, patient families, caregivers and/or healthcare professionalsACTIVE—
042Medical and scientific research in the field of health, wellness, and blood conditionsACTIVE—
044Healthcare and healthcare information services, namely, providing healthcare information concerning Von Willebrand disease and blood related diseases, its treatment and its impact on patients, patient families, caregivers and/or healthcare professionals; Providing a website featuring information in the field of health and medical conditions relating to the blood, bleeding conditions, and corresponding treatments; Healthcare and healthcare information services, namely, providing healthcare information concerning hemophilia, platelet dysfunction, perioperative bleeding, rare bleeding disorders, fibrinogen deficiency, anticoagulant reversal, and other blood related diseases, treatment and impacts on patients, patient families, caregivers and/or healthcare professionals; Healthcare and healthcare information services, namely, providing healthcare information concerning patient lifestyle and wellness for patients, caregivers, parents, teachers, coaches and friends impacted by bleeding conditions; Providing a website featuring healthcare information in the field of the diagnosis and treatment of blood conditions; Providing links to the web sites of others featuring information about the diagnosis and treatment of blood conditions and treatmentsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Sep 28, 2026MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 28, 2026ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 13, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 12, 2026EX5GSOU EXTENSION 5 GRANTED—
Jun 10, 2026AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jan 22, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 21, 2026EXT5SOU EXTENSION 5 FILED—
Jul 22, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 22, 2025EX4GSOU EXTENSION 4 GRANTED—
Jul 22, 2025EXT4SOU EXTENSION 4 FILED—
Jul 22, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 4, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 22, 2025EX3GSOU EXTENSION 3 GRANTED—
Jan 22, 2025EXT3SOU EXTENSION 3 FILED—
Jan 22, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 17, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 17, 2024EX2GSOU EXTENSION 2 GRANTED—
Jul 17, 2024EXT2SOU EXTENSION 2 FILED—
Jul 17, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 24, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 22, 2024EX1GSOU EXTENSION 1 GRANTED—
Jan 22, 2024EXT1SOU EXTENSION 1 FILED—
Jan 22, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 22, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 27, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 27, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 7, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 23, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 21, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 20, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 20, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 7, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 7, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 7, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 4, 2023DOCKASSIGNED TO EXAMINER—
Jan 15, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 22, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance